{"id":3195,"date":"2015-11-18T17:31:21","date_gmt":"2015-11-18T17:31:21","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=4826"},"modified":"2015-11-18T17:31:21","modified_gmt":"2015-11-18T17:31:21","slug":"anvisa-brazils-government-health-agency-approves-patients-request-for-marijuana-inc-s-real-scientific-hemp-oil-for-a-new-indication-park","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2015\/11\/18\/anvisa-brazils-government-health-agency-approves-patients-request-for-marijuana-inc-s-real-scientific-hemp-oil-for-a-new-indication-park\/","title":{"rendered":"ANVISA\u00a0\u2013 Brazil\u2019s Government Health Agency \u2013 Approves Patient\u2019s Request for Medical Marijuana, Inc.\u2019s Real Scientific Hemp Oil\u2122 for a New Indication: Parkinson\u2019s Disease"},"content":{"rendered":"
SAN DIEGO, CALIFORNIA \u2013 November 17, 2015<\/b>\u00a0\u2013\u00a0<\/span>Medical Marijuana, Inc.<\/span><\/a>\u00a0(OTC Pink: MJNA) is pleased to announce to shareholders and to the public that\u00a0its flagship\u00a0product\u00a0<\/span>Real Scientific Hemp Oil\u2122 (RSHO\u2122)<\/span><\/a>\u00a0has again made world history\u00a0as a\u00a0cannabis product to be approved on a case-by-case basis for Parkinson\u2019s disease by the Brazilian Government Health Agency ANVISA \u2013 which is responsible for approving citizen importation of medicines and botanical remedies from outside of Brazil.<\/span><\/p>\n Following <\/span>Epilepsy<\/span><\/a> (CDKL5 and Dravet Syndrome), which was the first indication to be approved, <\/span>Parkinson\u2019s disease<\/span><\/a> becomes the second approved indication of\u00a0<\/span>Medical Marijuana, Inc.<\/span><\/a>\u2019s\u00a0<\/span>RSHO\u2122<\/span><\/a>\u00a0by Brazil\u2019s ANVISA for importation with medical recommendation.\u00a0Medical Marijuana, Inc. and its partner\u00a0company\u00a0<\/span>HempMeds Brasil<\/span><\/a>\u2122 are working diligently within the framework of the Brazilian Government for approvals of at least five other indications.<\/span><\/p>\n MJNA\u2019s partner\u00a0<\/span>HempMeds Brasil<\/span><\/a>\u2122 is providing the\u00a0<\/span>RSHO\u2122<\/span><\/a>\u00a0exclusively for the Brazilian marketplace while under temporary case-by-case approval for several additional medical indications, subject to clinical trials within the country.<\/span><\/p>\n Today, any resident of Brazil who has a government-approved medical indication and who would like to have access to\u00a0<\/span>RSHO\u2122 hemp oil products<\/span><\/a>, may do so with a doctor’s prognosis, prescription and government-approved import documentation.\u00a0<\/span>ANVISA<\/span><\/a>\u00a0has issued a statement on the agency’s website and has also made an effort to explain how to apply for an import certificate. <\/span>HempMeds Brasil<\/span><\/a>\u2122 has been working for over a year on its formal product application and regulatory submission. The company expects this to take at least through 2015 to complete.<\/span><\/p>\n “The government of Brazil with their 1988 Constitutional right of free health care (SUS) to all citizens is again leading the way by putting the well-being of their people first,” states Stuart W. Titus, PhD \u2013 CEO of Medical Marijuana, Inc.\u00a0\u201c<\/span>RSHO\u2122<\/span><\/a>\u00a0products have been provisionally approved and are being reviewed for potentially five other medical indications, which are subject to future clinical trials \u2013 and the Company will continue to update shareholders on further developments.\u201d \u00a0<\/span><\/p>\n In 2005, the number of Parkinson\u2019s patients worldwide<\/a> was between 4.1 and 4.6 million. By the year 2030, those numbers are expected to more than double to 8.7 and 9.3 million patients according to <\/span>this report<\/span><\/a> put out by the European Parkinson\u2019s Disease Association. The Parkinson\u2019s Disease foundation states, in the U.S. alone, Parkinson\u2019s is estimated to cost nearly <\/span>$25 billion every year<\/span><\/a> in combined direct and indirect costs.<\/span><\/p>\n Hemp is widely regarded as a \u201cwhole food\u201d and \u201csuper food.\u201d<\/span> MJNA<\/span><\/a>\u2019s cannabidiol<\/span> (CBD) hemp oil<\/span><\/a> is derived from the mature stalk of the hemp plant and<\/span> is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic\/euphoric effects of THC. Although CBD hemp oil products from<\/span> MJNA<\/span><\/a> are readily available in and ship to all U.S. states, territories, and districts, hemp oil products are handled quite differently in Brazil.<\/span><\/p>\n Until recently, the Brazilian government treated anything derived from cannabis \u2013 even hemp \u2013 as illegal and, therefore, a controlled substance. In a series of landmark rulings, the Brazilian government began permitting the importation of hemp<\/span> CBD oil products<\/span><\/a> \u2013 including<\/span> RSHO<\/span><\/a> \u2013 with registration by the Federal government agency ANVISA. The Federal government agency also<\/span> removed CBD from its prohibited substance use<\/span><\/a> list.<\/span><\/p>\n For information on the indication of <\/span>Parkinson\u2019s disease in Brazil<\/span><\/a> and to learn how to import cannabidiol for Parkinson\u2019s disease, visit the HempMeds Brasil\u2122 website <\/span>here<\/span><\/a>.<\/span><\/p>\n About HempMeds Brasil<\/b>\u2122<\/span><\/p>\n HempMeds Brasil<\/span><\/a>\u2122 is a corporate affiliated company of\u00a0<\/span>Medical Marijuana, Inc.<\/span><\/a>\u00a0(OTC Pink: MJNA) and is its exclusive\u00a0distributor of RSHO\u2122.\u00a0<\/span>HempMeds<\/span><\/a>\u00a0Brasil\u2122\u00a0offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of Brazil. For more information on\u00a0<\/span>HempMeds<\/span><\/a>\u00a0Brasil\u2122 and their all-natural hemp oil products, visit:\u00a0<\/span>http:\/\/www.hempmeds.com.br<\/span><\/a>. The Company invites the public to get involved in the conversation on the expanding cannabis industry with\u00a0<\/span>HempMeds<\/span><\/a>\u00a0Brasil\u2122 through the Company’s social media channels\u00a0<\/span>Facebook<\/span><\/a>,\u00a0<\/span>Twitter<\/span><\/a>\u00a0and\u00a0<\/span>blog<\/span><\/a>.<\/span><\/p>\n About Medical Marijuana Inc.<\/i><\/b> MJNA\u2019s Cannabis Product Approved for Citizen Importation in Brazil for Indication of Parkinson\u2019s SAN DIEGO, CALIFORNIA \u2013 November 17, 2015\u00a0\u2013\u00a0Medical Marijuana, Inc.\u00a0(OTC Pink: MJNA) is pleased to announce to shareholders and to the public that\u00a0its flagship\u00a0product\u00a0Real Scientific Hemp Oil\u2122 (RSHO\u2122)\u00a0has again made world history\u00a0as a\u00a0cannabis product to be approved on a case-by-case basis for Parkinson\u2019s […]<\/p>\n","protected":false},"author":1,"featured_media":3196,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3,4,2],"tags":[192,180],"class_list":["post-3195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-hempmeds-brasil","category-press-releases","tag-hempmeds-brazil","tag-real-scientific-hemp-oil"],"yoast_head":"\n
\n<\/i><\/b>The mission of Medical Marijuana, Inc. (OTC Pink: MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: <\/span>www.MedicalMarijuanaInc.com<\/span><\/a>.<\/span> \t<\/p>\n","protected":false},"excerpt":{"rendered":"